BDBM115045 5-bromanyl-N-[4-(2-methyl-1,3-thiazol-4-yl)phenyl]furan-2-carboxamide::5-bromo-N-[4-(2-methyl-1,3-thiazol-4-yl)phenyl]-2-furamide::5-bromo-N-[4-(2-methyl-1,3-thiazol-4-yl)phenyl]furan-2-carboxamide::5-bromo-N-[4-(2-methyl-4-thiazolyl)phenyl]-2-furancarboxamide::5-bromo-N-[4-(2-methylthiazol-4-yl)phenyl]-2-furamide::MLS001178354::SMR000477842::cid_983644

SMILES Cc1cc([C@H](Oc2ccc3c(c2)OCCC3=O)c2ccncc2)ccc1C(N)=O

InChI Key InChIKey=QKLDLURNVHPAKF-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 115045   

TargetHLA-DR4 protein(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 115045BDBM115045((*S)-2-methyl-4-(((4-oxochroman-7-yl)oxy)(pyridin-...)
Affinity DataIC50: 830nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Confirmation testing of small molecules identifie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/18/2026
Entry Details
US Patent